Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials

Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials

Abstract Background Renin-angiotensin system inhibitors (RASIs), either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, are widely used in patients with non-dialysis chronic kidney disease, as a renin-angiotensin system (RAS) blockade has renoprotective effects. Several st...

Full description

Bibliographic Details
Main Authors: Minoru Ito, Yosuke Saka, Yusuke Kuroki, Kaoru Yasuda, Hiraku Tsujimoto, Yasushi Tsujimoto, Hidemichi Yuasa, Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Renal Replacement Therapy
Subjects:
Peritoneal dialysis
Renin-angiotensin system inhibitors
Residual renal function
Systematic review
Online Access:http://link.springer.com/article/10.1186/s41100-019-0238-3

Internet

http://link.springer.com/article/10.1186/s41100-019-0238-3

Similar Items